Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial |
journalArticle |
2016 |
Piperno-Neumann, S.; Le Deley, M. C.; Redini, F.; Pacquement, H.; Marec-Berard, P.; Petit, P.; Brisse, H.; Lervat, C.; Gentet, J. C.; Entz-Werle, N.; Italiano, A.; Corradini, N.; Bompas, E.; Penel, N.; Tabone, M. D.; Gomez-Brouchet, A.; Guinebretiere, J. M.; Mascard, E.; Gouin, F.; Chevance, A.; Bonnet, N.; Blay, J. Y.; Brugieres, L.; Sarcoma Group of, Unicancer; French Society of Pediatric, Oncology; French Sarcoma, Group |
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials |
journalArticle |
2016 |
Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I. |
Impact of dermatologic adverse events induced by targeted therapies on quality of life |
journalArticle |
2016 |
Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S. |
Postoperative radiotherapy for non-small cell lung cancer |
journalArticle |
2016 |
Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists |
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis |
journalArticle |
2016 |
Lueza, B.; Rotolo, F.; Bonastre, J.; Pignon, J. P.; Michiels, S. |
Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery |
journalArticle |
2016 |
De Felice, F.; Blanchard, P.; Levy, A.; Nguyen, F.; Gorphe, P.; Janot, F.; Temam, S.; Tao, Y. |
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients |
journalArticle |
2016 |
Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F. |
Impact of dermatologic adverse events induced by targeted therapies on quality of life |
journalArticle |
2016 |
Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S. |
45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims? |
journalArticle |
2016 |
Mazeron, R.; Petit, C.; Rivin, E.; Limkin, E.; Dumas, I.; Maroun, P.; Annede, P.; Martinetti, F.; Seisen, T.; Lefkopoulos, D.; Chargari, C.; Haie-Meder, C. |
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer |
journalArticle |
2016 |
Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P. |
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique |
journalArticle |
2016 |
Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S. |
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients |
journalArticle |
2016 |
Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C. |
Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery |
journalArticle |
2016 |
De Felice, F.; Blanchard, P.; Levy, A.; Nguyen, F.; Gorphe, P.; Janot, F.; Temam, S.; Tao, Y. |
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice |
journalArticle |
2016 |
Michiels, S.; Ternes, N.; Rotolo, F. |
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience |
journalArticle |
2016 |
Helissey, C.; Biondani, P.; Roquet, F.; Lanoy, E.; Mir, O.; Varga, A.; Massard, C.; Gazzah, A.; Ribrag, V.; Bahleda, R.; Postel-Vinay, S.; Angevin, E.; Deutsch, E.; Soria, J. C.; Hollebecque, A. |
Innovations for phase I dose-finding designs in pediatric oncology clinical trials |
journalArticle |
2016 |
Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X. |
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01) |
journalArticle |
2016 |
Tacher, V.; Le Deley, M. C.; Hollebecque, A.; Deschamps, F.; Vielh, P.; Hakime, A.; Ileana, E.; Abedi-Ardekani, B.; Charpy, C.; Massard, C.; Rosellini, S.; Gajda, D.; Celebic, A.; Ferte, C.; Ngo-Camus, M.; Gouissem, S.; Koubi-Pick, V.; Andre, F.; Vassal, G.; Deandreis, D.; Lacroix, L.; Soria, J. C.; De Baere, T. |
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer |
journalArticle |
2016 |
Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M. |
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study |
journalArticle |
2016 |
Bayar, M. A.; Le Teuff, G.; Michiels, S.; Sargent, D. J.; Le Deley, M. C. |
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours |
journalArticle |
2016 |
Gizzi, M.; Oberic, L.; Massard, C.; Poterie, A.; Gwenael, L. T.; Loriot, Y.; Albiges, L.; Baciarello, G.; Michels, J.; Bossi, A.; Blanchard, P.; Escudier, B.; Fizazi, K. |
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity |
journalArticle |
2016 |
Petit, C.; Dumas, I.; Chargari, C.; Martinetti, F.; Maroun, P.; Doyeux, K.; Tailleur, A.; Haie-Meder, C.; Mazeron, R. |
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial |
journalArticle |
2016 |
Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L. |
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic |
journalArticle |
2016 |
Delaloge, S.; Bonastre, J.; Borget, I.; Garbay, J. R.; Fontenay, R.; Boinon, D.; Saghatchian, M.; Mathieu, M. C.; Mazouni, C.; Rivera, S.; Uzan, C.; Andre, F.; Dromain, C.; Boyer, B.; Pistilli, B.; Azoulay, S.; Rimareix, F.; Bayou el, H.; Sarfati, B.; Caron, H.; Ghouadni, A.; Leymarie, N.; Canale, S.; Mons, M.; Arfi-Rouche, J.; Arnedos, M.; Suciu, V.; Vielh, P.; Balleyguier, C. |
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues |
journalArticle |
2016 |
Martelli, N.; van den Brink, H.; Borget, I. |
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial |
journalArticle |
2016 |
Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K. |
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience |
journalArticle |
2016 |
Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. |
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence |
journalArticle |
2016 |
Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C. |
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination |
journalArticle |
2016 |
Boutros, C.; Tarhini, A.; Routier, E.; Lambotte, O.; Ladurie, F. L.; Carbonnel, F.; Izzeddine, H.; Marabelle, A.; Champiat, S.; Berdelou, A.; Lanoy, E.; Texier, M.; Libenciuc, C.; Eggermont, A. M.; Soria, J. C.; Mateus, C.; Robert, C. |
Incorporation of nested frailties into semiparametric multi-state models |
journalArticle |
2016 |
Rotolo, F.; Rondeau, V.; Legrand, C. |
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer |
journalArticle |
2016 |
Lamartina, L.; Ippolito, S.; Danis, M.; Bidault, F.; Borget, I.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Blanchard, P.; Terroir, M.; Deandreis, D.; Schlumberger, M.; Baudin, E.; Leboulleux, S. |
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers |
journalArticle |
2016 |
Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S. |
Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial |
journalArticle |
2016 |
Ouldamer, L.; Bonastre, J.; Brunet-Houdard, S.; Body, G.; Giraudeau, B.; Caille, A. |
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research |
journalArticle |
2016 |
Blanchard, P.; Garden, A. S. |
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer |
journalArticle |
2016 |
Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P. |
Equal access to innovative therapies and precision cancer care |
journalArticle |
2016 |
Buzyn, A.; Blay, J. Y.; Hoog-Labouret, N.; Jimenez, M.; Nowak, F.; Deley, M. C.; Perol, D.; Cailliot, C.; Raynaud, J.; Vassal, G. |
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma |
journalArticle |
2016 |
Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G. |
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis |
journalArticle |
2016 |
Lueza, B.; Rotolo, F.; Bonastre, J.; Pignon, J. P.; Michiels, S. |
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies |
journalArticle |
2016 |
Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A. |
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study |
journalArticle |
2016 |
Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C. |
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials |
journalArticle |
2016 |
Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T. |